000			01441 a2200421 4500
005			20250511152208.0
264		0	_c19750913
008			197509s 0 0 ita d
022			_a0026-4725
040			_aNLM _beng _cNLM
100	1		_aTomasi, A M
245	0	0	_a[Clinical experiences with the vascular action of dihydroergocristine]. _h[electronic resource]
260			_bMinerva cardioangiologica _cJan 1975
300			_a7-19 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAged
650	0	4	_aArteriosclerosis _xdrug therapy
650	0	4	_aArteriosclerosis Obliterans _xdrug therapy
650	0	4	_aBlood Flow Velocity
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCerebrovascular Circulation _xdrug effects
650	0	4	_aCoronary Disease _xdrug therapy
650	0	4	_aDihydroergotoxine _xadministration & dosage
650	0	4	_aErgoloid Mesylates _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInjections, Intra-Arterial
650	0	4	_aInjections, Intramuscular
650	0	4	_aInjections, Intravenous
650	0	4	_aIntermittent Claudication _xdrug therapy
650	0	4	_aIntracranial Arteriosclerosis _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aSkin Temperature _xdrug effects
700	1		_aBaggioni, G F
700	1		_aPozzar, C
773	0		_tMinerva cardioangiologica _gvol. 23 _gno. 1 _gp. 7-19
999			_c815566 _d815566